Xenitra Limited (ASX:XEN)

Australia · Delayed Price · Currency is AUD

0.0020

-0.0005 (-20.00%)

Sep 29, 2026, 9:59 AM AEST

Market Cap	8.56M -5.6%
Revenue (ttm)	20.34M -49.0%
Net Income	-5.18M
EPS	-0.00
Shares Out	4.28B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,100
Open	0.0020
Previous Close	0.0025
Day's Range	0.0020 - 0.0020
52-Week Range	0.0020 - 0.0040
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Xenitra

Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritio... [Read more]

Industry Department Stores

Sector Consumer Discretionary

Founded 2011

Employees 114

Stock Exchange Australian Securities Exchange

Ticker Symbol XEN

Full Company Profile

Financial Performance

In fiscal year 2026, Xenitra's revenue was 20.34 million, a decrease of -49.01% compared to the previous year's 39.89 million. Losses were -5.18 million, 48.9% more than in 2025.

Financial Statements